文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机器学习方法识别COVID-19患者拔管失败的预测因素

Predictors for extubation failure in COVID-19 patients using a machine learning approach.
PubMed 文献 · Crit Care · 2021-12-27
一句话结论在重症COVID-19患者中,拔管失败最重要的预测因素是通气模式与参数、炎症指标、神经状态和体重指数,这些因素应常规记录于电子病历。

本研究利用荷兰数据仓库中3464例成人重症COVID-19患者的高颗粒度数据,纳入至少有一次拔管尝试的插管患者,排除转院、入院不足24小时及数据提取时仍在院的患者,最终883例进入模型推导。主要结局为拔管后7天内无再插管或死亡,次要结局为48小时内。再插管率48小时内为13.4%、第7天为18.9%,死亡率分别为0.6%和1.0%。梯度提升模型表现最佳(AUC 0.70),通气特征与设置是最重要的预测因素。

要点

  • 梯度提升模型预测拔管失败的AUC为0.70,最重要的预测因素为通气特征与设置。
  • 与中位数相比,控制通气模式持续时间超过4天、拔管前最后一天吸入氧浓度高于35%、潮气量超过8 ml/kg理想体重、辅助通气时间短于2天与拔管失败相关。
  • 较高的C反应蛋白和白细胞计数、较低的血小板计数、较低的格拉斯哥昏迷评分和较低的体重指数也与拔管失败相关。
  • 再插管率48小时内为13.4%、第7天为18.9%,死亡率分别为0.6%和1.0%。
  • 作者认为这些预测因素应常规记录于电子病历。

适用人群与场景

  • 荷兰数据仓库中3464例成人重症COVID-19患者,纳入所有至少有一次拔管尝试的插管患者。
  • 排除转院患者、入院不足24小时的患者以及数据提取时仍在院的患者。

研究设计与关键结果

  • 研究类型为多中心机器学习模型开发与验证,数据来自荷兰数据仓库,最终883例患者进入模型推导。
  • 主要结局为拔管后7天内无再插管或死亡,次要结局为48小时内无再插管或死亡。
  • 再插管率48小时内为13.4%,第7天为18.9%;死亡率48小时内为0.6%,第7天为1.0%。
  • 采用五折嵌套交叉验证训练和验证多种机器学习算法,梯度提升模型表现最佳,AUC为0.70。
  • 使用Shapley加性解释估计预测因素重要性,通过部分依赖图估计拔管失败相对概率的截断值。
  • 与中位数相比,控制通气模式持续时间超过4天、拔管前最后一天吸入氧浓度高于35%、潮气量超过8 ml/kg理想体重、辅助通气时间短于2天与拔管失败相关。
  • 与中位数相比,较高的C反应蛋白和白细胞计数、较低的血小板计数、较低的格拉斯哥昏迷评分和较低的体重指数与拔管失败相关。

证据类型、等级与局限

  • 证据类型为机器学习模型开发与验证研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,通气设置、炎症参数、神经状态和体重指数是重症COVID-19患者拔管失败最重要的预测因素,应常规记录于电子病历。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Determining the optimal timing for extubation can be challenging in the intensive care. In this study, we aim to identify predictors for extubation failure in critically ill patients with COVID-19.

METHODS: We used highly granular data from 3464 adult critically ill COVID patients in the multicenter Dutch Data Warehouse, including demographics, clinical observations, medications, fluid balance, laboratory values, vital signs, and data from life support devices. All intubated patients with at least one extubation attempt were eligible for analysis. Transferred patients, patients admitted for less than 24 h, and patients still admitted at the time of data extraction were excluded. Potential predictors were selected by a team of intensive care physicians. The primary and secondary outcomes were extubation without reintubation or death within the next 7 days and within 48 h, respectively. We trained and validated multiple machine learning algorithms using fivefold nested cross-validation. Predictor importance was estimated using Shapley additive explanations, while cutoff values for the relative probability of failed extubation were estimated through partial dependence plots.

RESULTS: A total of 883 patients were included in the model derivation. The reintubation rate was 13.4% within 48 h and 18.9% at day 7, with a mortality rate of 0.6% and 1.0% respectively. The grandient-boost model performed best (area under the curve of 0.70) and was used to calculate predictor importance. Ventilatory characteristics and settings were the most important predictors. More specifically, a controlled mode duration longer than 4 days, a last fraction of inspired oxygen higher than 35%, a mean tidal volume per kg ideal body weight above 8 ml/kg in the day before extubation, and a shorter duration in assisted mode (< 2 days) compared to their median values. Additionally, a higher C-reactive protein and leukocyte count, a lower thrombocyte count, a lower Glasgow coma scale and a lower body mass index compared to their medians were associated with extubation failure.

CONCLUSION: The most important predictors for extubation failure in critically ill COVID-19 patients include ventilatory settings, inflammatory parameters, neurological status, and body mass index. These predictors should therefore be routinely captured in electronic health records.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Fleuren LM, Dam TA, Tonutti M, et al. Predictors for extubation failure in COVID-19 patients using a machine learning approach. Crit Care. 2021. PMID: 34961537. doi:10.1186/s13054-021-03864-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。